StockData
DexCom Inc logo

DexCom Inc (DXCM) stock

DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3030% below fair value
$82.52+0.48 (+0.59%)

Close on Nov 18, 2026Market cap $30.78BP/E 32.5Yield –

DexCom operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

DexCom's operating cash flow for the twelve months ending Sep 30, 2026 was $1.41B, down 2.3% year over year. For fiscal 2025 it was $1.44B, up 45.6% from the year before. Over ten years it grew 40.2% a year on average. The highest annual figure on record is $1.44B in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.44B+45.6%
FY2024Dec 31, 2024$989.50M+32.2%
FY2023Dec 31, 2023$748.50M+11.8%
FY2022Dec 31, 2022$669.50M+51.3%
FY2021Dec 31, 2021$442.50M-7.0%
FY2020Dec 31, 2020$475.60M+51.2%
FY2019Dec 31, 2019$314.50M+155.3%
FY2018Dec 31, 2018$123.20M+33.9%
FY2017Dec 31, 2017$92.00M+63.7%
FY2016Dec 31, 2016$56.20M+14.7%
FY2015Dec 31, 2015$49.00M+107.6%
FY2014Dec 31, 2014$23.60M+883.3%
FY2013Dec 31, 2013$2.40M–
FY2012Dec 31, 2012-$33.10M–
FY2011Dec 31, 2011-$30.10M–
FY2010Dec 31, 2010-$42.70M–
FY2009Dec 31, 2009-$39.39M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$325.60M-50.7%
Q2 FY2026Jun 30, 2026$269.20M-11.2%
Q1 FY2026Mar 31, 2026$525.60M+186.0%
Q4 FY2025Dec 31, 2025$294.00M-2.5%
Q3 FY2025Sep 30, 2025$659.90M+230.8%
Q2 FY2025Jun 30, 2025$303.00M+8.4%
Q1 FY2025Mar 31, 2025$183.80M-12.1%
Q4 FY2024Dec 31, 2024$301.40M+125.6%
Q3 FY2024Sep 30, 2024$199.50M-25.9%
Q2 FY2024Jun 30, 2024$279.40M+46.8%
Q1 FY2024Mar 31, 2024$209.20M+34.6%
Q4 FY2023Dec 31, 2023$133.60M+0.8%
Q3 FY2023Sep 30, 2023$269.20M-8.2%
Q2 FY2023Jun 30, 2023$190.30M+10.1%
Q1 FY2023Mar 31, 2023$155.40M+118.9%
Q4 FY2022Dec 31, 2022$132.50M+25.2%
Q3 FY2022Sep 30, 2022$293.20M+18.6%
Q2 FY2022Jun 30, 2022$172.80M+180.5%
Q1 FY2022Mar 31, 2022$71.00M+155.4%
Q4 FY2021Dec 31, 2021$105.80M-38.5%
Q3 FY2021Sep 30, 2021$247.30M+67.5%
Q2 FY2021Jun 30, 2021$61.60M-60.0%
Q1 FY2021Mar 31, 2021$27.80M+1363.2%
Q4 FY2020Dec 31, 2020$172.00M+19.7%
Q3 FY2020Sep 30, 2020$147.60M+56.2%
Q2 FY2020Jun 30, 2020$154.10M+138.9%
Q1 FY2020Mar 31, 2020$1.90M-83.9%
Q4 FY2019Dec 31, 2019$143.70M+326.4%
Q3 FY2019Sep 30, 2019$94.50M+66.4%
Q2 FY2019Jun 30, 2019$64.50M+55.8%
Q1 FY2019Mar 31, 2019$11.80M–
Q4 FY2018Dec 31, 2018$33.70M-18.2%
Q3 FY2018Sep 30, 2018$56.80M+56.9%
Q2 FY2018Jun 30, 2018$41.40M+189.5%
Q1 FY2018Mar 31, 2018-$8.70M-3000.0%
Q4 FY2017Dec 31, 2017$41.20M+209.8%
Q3 FY2017Sep 30, 2017$36.20M–
Q2 FY2017Jun 30, 2017$14.30M–
Q1 FY2017Mar 31, 2017$300.00K–
Q4 FY2016Dec 31, 2016$13.30M–

More DexCom figures

See a number that looks wrong?